About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

Dose-Ranging Study of A006 DPI, in Adult Asthma Patients

NCT01174732·4 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Amphastar Pharmaceuticals, Inc.

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

With mild-to-moderate persistent asthma for at least 6 months and having used inhaled beta-agonist for asthma control;
Must demonstrate response to beta 2 agonist by Reversing;
Must demonstrate ability to use DPI;
Females of child-bearing potential must be non-pregnant, non-lactating, and practicing a clinically acceptable form of birth control;
Additional Criteria

You may not be if

Smoking history of ≥ 10 pack-years, or having smoked within 6 months;
Upper respiratory tract infections
Asthma exacerbations;
Known intolerance or hypersensitivity to any of the ingredients of the study drug or Proventil®;
Use of prohibited drugs or failure to observe the drug washout restrictions;
Having been on other clinical drug/device studies in the last 30 days;
Other Criteria

The record

StatusCompleted

PhasePhase 2

Taking part26

StartedJul 2010

UpdatedApr 19, 2017

Conditions

Asthma Bronchospasm

Where4

Amphastar Site 0001
San Jose, California, United States
Amphastar Site 0007
Centennial, Colorado, United States
Amphastar Site 0008
Denver, Colorado, United States